Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
Dr Reddy’s Q2 profit falls 36%, plans semaglutide relaunch in November | Today News
Lower US sales of generic Revlimid dragged down second-quarter earnings, but double-digit growth in base markets and the upcoming relaunch of semaglutide offer near-term relief.
Ähnliche Seiten
Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginally - The Economic Times
https://economictimes.indiatimes.com/markets/stocks/earnings/dr-reddys-q2-results-net-profit-falls-36-yoy-to-rs-913-crore-revenue-declines-marginally/articleshow/135147475.cms
Torrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27
https://www.freepressjournal.in/business/torrent-pharma-profit-falls-96-per-cent-dr-reddys-slumps-36-pc-in-q2-fy27DRL says cap on trade margins a positive, posts 36% dip in Q2 PAT - The Economic Times
https://economictimes.indiatimes.com/markets/stocks/earnings/drl-says-cap-on-trade-margins-a-positive-posts-36-dip-in-q2-pat/articleshow/135161325.cms